Artiva Biotherapeutics (ARTV) Long-Term Deferred Tax (2024)

Artiva Biotherapeutics' (ARTV) quarterly Long-Term Deferred Tax came in at $2.8 million in Q2 2024.

Artiva Biotherapeutics (ARTV) Long-Term Deferred Tax (2024) Analysis & Trends

Artiva Biotherapeutics (ARTV) has 1 years of Long-Term Deferred Tax data on file, last reported at $2.8 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Artiva Biotherapeutics	249.99 Mn	249.99 Mn	-

Download Data

Date	Value
Jun 30, 2024	2.80 Mn